Visit Apellis Pharmaceuticals, Inc., at booth #3307!
Apellis Pharmaceuticals, Inc., is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in Complement, at the forefront of targeted C3 therapies, we aim to develop transformative therapies for a broad range of debilitating diseases that are driven by uncontrolled or excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology.